Access Gaps for Pediatric CD19 CAR T-Cell Therapy in Europe
Pediatric CD19 CAR-T therapy access remains starkly uneven across Europe, with over 25% of surveyed nations lacking any available treatment. This disparity, driven by prohibitive costs and infrastructure gaps, creates ... Read More